Fundraising Fox

Maculaser

Helsinki, FI · Founded 2020 · 5 employees on LinkedIn · 2 known investors

Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.

Founders & leadership

JTJani Tirronen
Jani TirroneninCEO
TTTeemu Turunen
Teemu TuruneninChief Scientific Officer, PhD
OKOssi Kaikkonen
Ossi KaikkoneninHead of Product
JNJaakko Nieminen
Jaakko NiemineninCTO, PhD
AVAki Vartiainen
Aki VartiainenClinical Trial Manager

Investors · 2

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Maculaser do?
Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.
Who are Maculaser's investors?
Maculaser's investors include Innovestor Ventures, ZEISS Ventures.
Where is Maculaser headquartered?
Maculaser is headquartered in Helsinki, FI.